Scheer expert Ralf Schmidt has published an article on digitalization and processes in the biotechnology industry in the August-Wilhelm Scheer Institute's trade magazine IM+io. Factors such as global competition, growing regulatory requirements, and pressure to become more sustainable are posing major challenges for biotech companies.
The article illustrates how these hurdles can be overcome with strategically planned, process-oriented digitalization - and how SAP technologies enable seamless integration of research, production, and management. The result is end-to-end data processing, real-time transparency, greater efficiency, better compliance, and more sustainable processes.
Access the article in full via the link below to find out how fragmented processes can be transformed into a networked, future-proof value chain.
(Please note: the article is only available in German)
